This is interesting as the injection is given in the thigh of your leg and there’s a video at the site that shows how the product is used. It is a one time injection/dose and also tells you to take the device to your doctor for disposal. If you get stung by a bee and you are allergic this looks to be an immediate solution to slow down a reaction and give you time to also seek medical advice as it is not supposed to be a substitute. The treatment itself could also have some adverse reactions such as those with diabetes could shoot up their glucose levels and a temporary raise of one’s heart rate could also occur but the information states that these are usually temporary conditions with use of the product.
Unless I am missing anything here, this is not an over the counter product and will need to be prescribed by a physician as that makes sense as for those who do not have allergies at an accelerated level what would be the use. It does require batteries and has training material for practice purposes. This looks to be a potential lifesaver with allergic reactions or at least an available methodology to use before immediate damages goes too far before one can get to the doctor or to a hospital. BD
RICHMOND, Va.--(BUSINESS WIRE)--Intelliject, Inc. announced that the U.S. Food and Drug Administration (FDA) approved Auvi-Q™ (epinephrine injection, USP) for the emergency treatment of life-threatening allergic reactions in people who are at risk or have a history of anaphylaxis. This is the first-and-only compact auto-injector with audio and visual cues that guide patients and caregivers step-by-step through the injection process.
Eric and Evan Edwards, twin brothers who jointly founded Intelliject and who themselves suffer from severe, life-threatening allergies, developed Auvi-Q with a team of world-class engineers and scientists using a comprehensive Human Factors Engineering process. This development process incorporated real-world experiences and feedback from patients and caregivers.
“In developing Auvi-Q, our goal is to offer patients and caregivers an innovative treatment option that is easy to use in an emergency,” said Eric Edwards, Chief Science Officer, Intelliject, Inc. “As allergy sufferers, my twin brother and I know first-hand how stressful it can be when you experience a severe allergic reaction.
Auvi-Q’s small size and intuitive design, as well as its first-in-class prompt system that talks a user through the injection process, will help patients and caregivers manage a life-threatening allergic reaction.”
Auvi-Q contains epinephrine, the well-established, first-line treatment for severe, life-threatening allergic reactions that may occur as a result of exposure to allergens including nuts, shellfish, dairy, eggs, insect bites, latex and medication, and others.